id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0582-0055,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner; Reopening of the Comment Period",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-03-23T04:00:00Z,2012,3,2012-03-23T04:00:00Z,2012-04-10T03:59:59Z,2023-10-25T16:01:08Z,2012-06948,0,0,0900006480fdf3d2
FDA-2009-N-0582-0040,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner; Notice of Availability of Study Data",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-01-27T05:00:00Z,2012,1,2012-01-27T05:00:00Z,2012-02-28T04:59:59Z,2023-10-25T16:02:27Z,2012-01672,0,0,0900006480fa7047